التفاصيل البيبلوغرافية
| العنوان: |
RPA3-UMAD1 rs12702634 and rheumatoid arthritis–associated interstitial lung disease in European ancestry. |
| المؤلفون: |
Juge, Pierre-Antoine, Sparks, Jeffrey A, Gazal, Steven, Ebstein, Esther, Borie, Raphaël, Debray, Marie-Pierre, Kannengiesser, Caroline, McDermott, Gregory C, Cui, Jing, Hayashi, Keigo, Doyle, Tracy J, Moorsel, Coline H M van, Vis, Joanne J van der, Grutters, Jan C, Knevel, Rachel, Heckert, Sascha L, Vasarmidi, Eirini, Antoniou, Katerina M, Mil, Annette H M van der Helm van, Boileau, Catherine |
| المصدر: |
Rheumatology Advances in Practice; 2024, Vol. 8 Issue 2, p1-5, 5p |
| مصطلحات موضوعية: |
RHEUMATOID arthritis, INTERSTITIAL lung diseases, SMOKING |
| مستخلص: |
Objective Recently, a genome-wide association study identified an association between RA-associated interstitial lung disease (ILD) and RPA3-UMAD1 rs12702634 in the Japanese population, especially for patients with a usual interstitial pneumonia (UIP) pattern. We aimed to replicate this association in a European population and test for interaction with MUC5B rs35705950. Methods In this genetic case–control association study, patients with RA and ILD and controls with RA and no ILD were included from France, the USA and the Netherlands. Only cases and controls from European genetic ancestries determined by principal components analysis were included in the analyses. RA was defined by the 1987 ACR or 2010 ACR/EULAR criteria and ILD by chest high-resolution CT scan, except in the control dataset from the Netherlands, where the absence of ILD was determined by chart review. Patients were genotyped for RPA3-UMAD1 rs12702634 and MUC5B rs35705950. Associations were tested using logistic regression adjusted for sex, age at RA onset, age at ILD onset or at certified absence of ILD, tobacco smoking status and country of origin. Results Among the 883 patients included, 322 were RA-ILD cases (36.5%). MUC5B rs35705950 was strongly associated with RA-ILD in all datasets {combined adjusted odds ratio [OR] 2.9 [95% CI 2.1, 3.9], P = 1.1 × 10−11. No association between RPA3-UMAD1 rs12702634 and RA-ILD was observed [combined OR 1.2 (95% CI 0.8, 1.6), P = 0.31. No interaction was found between RPA3-UMAD1 rs12702634 and MUC5B rs35705950 (P = 0.70). Conclusion Our findings did not support a contribution of RPA3-UMAD1 rs12702634 to the overall RA-ILD susceptibility in the European population. [ABSTRACT FROM AUTHOR] |
|
Copyright of Rheumatology Advances in Practice is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder